Neoantigen Summit Europe

Almac Sciences is delighted to be exhibiting at this years’ Neoantigen Summit EU, taking place April 30 – May 01 in Amsterdam – Supercharging Neoantigen-Based Therapeutics & Cancer Vaccines Through Optimised Neoantigen Prediction & Streamlined Clinical Translation for Faster Approval.

This, the 7th Annual Summit, is seeking to Accelerate Clinically Relevant & Effective Neoantigen Based Therapies to Patients. It is the only summit in Europe dedicated to advancing exclusive tumour antigen discovery and personalised therapeutic development within the world of immunotherapy. More than 150 experts together will be navigating the validation of neoantigen targets and review methodologies/technologies to support with translating neoantigen-based studies effectively to the clinic.

To find out more about the event, visit the website here.

Request a meeting with us today, we look forward to meeting you there and discussing your needs.